Pharmaceutical giant Regeneron has promised to prioritise the “ethical use” of the sequenced DNA data of more than 15 million ...

Dow Jones Top Company Headlines at 7 PM ET: Regeneron to Buy 23andMe Out of Bankruptcy for $256 Million | Jamie ... The DNA testing company would sell for a fraction of its peak valuation of $6 ...

The once-popular genetic testing company will be acquired by Regeneron after filing for bankruptcy, but the questions about ...

The deal would put the DNA data of millions of customers in the hands of a pharmaceutical company, which hopes to supercharge ...

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer ...

Genetic testing company 23andMe isn’t going away, despite declaring bankruptcy. The company and nearly all of its assets, ...

The company, which was founded in 2006, rose to prominence by offering at-home DNA testing kits that allowed people to ...

23andMe will keep offering customers its DNA testing services after being bought out of bankruptcy. New York-based biotech ...

Regeneron Pharmaceuticals announced on Monday that it will acquire the genetic testing business and most assets of 23andMe ...

The proposed transaction with Regeneron includes 23andMe’s personal genome service and total health and research services.

How exactly 23andMe will shake out after the Regeneron purchase is to be seen. The company has taken a dramatic fall in ...

It will acquire genetic data of more than 15 million customers – raising privacy concerns from individuals who had willingly ...